Clinical Pharmacology Study Group was established in 1989 in Worcester, Massachusetts by Doctor Birbara and Mary Coughlin, RN. Both have been involved in clinical trials since 1975 and wanted to create a dedicated research center to become involved with the newest medications in the field of rheumatology. In the early years, we worked with the traditional anti-inflammatory medications (NSAIDs) in conjunction with stomach protecting agents to find a way to administer NSAIDs more safely and with less GI irritation.
In the mid 1990's, when the COX II inhibitor medications were being developed, our group grew rapidly in order to keep up with the studies we were asked to do. CPSG was excited to be part of the testing for Celebrex, Vioxx, Bextra, and other COX II inhibitors. In the late 1990's, we entered the era of biologicals for the treatment of autoimmune diseases such as rheumatoid arthritis (RA), psoriasis, psoriatic arthritis (PSA) and Crohn's Disease. These past few years have been the most exciting since we have been able to witness first hand the tremendous efficacy and improvements in quality of life of our patients. Learn More
What’s New
Open Enrollment for Clinical Studies. CPSG is now accepting applications for various auto-immune trial programs
Enrollment studies include: Rheumatoid Arthritis, Fibromyalgia, Psoriasis, Diabetic Neuropathy, Psoriatic Arthritis, Scleroderma, Ankylosing & Raynauds.
Are you interested in learning more about this program? Select the study of your interest and click "Go."
Meet our staff
 | Charles Birbara MD |